109.

M. Spreafico and M. P. Jacobson.  “In silico prediction of brain exposure: drug free fraction, unbound brain to plasma concentration ratio and equilibrium half-life”, Current Topics in Medicinal Chemistry, 13 (2013) 813-820.  Online  PMC4005893

106.

Z. Li, B. M. Silber, S. Rao, J. Gever, C. Bryant, A. Gallardo-Godoy, E. Dolghih, K. Widjaja, M. Elepano, M. P. Jacobson, S. B. Prusiner and A. R. Renslo.  “2-Aminothiazoles with Improved Pharmacotherapeutic Properties for Treatment of Prion Disease”, ChemMedChem, 8 (2013) 847-857.  PMC3984044

103.

B. M. Silber, S. Rao, K. L. Fife, A. Gallardo-Godoy, A. R. Renslo, D. K. Dalvie, K. Giles, Y. Freyman, M. Elepano, J. R. Gever, B. Lam, M. P. Jacobson, Y. Huang, L. Z. Benet, S. B. Prusiner.  “Pharmacokinetics and metabolism of 2-aminothiazoles with antiprion activity in mice”, Pharmaceutical Research, 30 (2013) 932-950.  PMC3640342

101.

E. Dolghih and M. P. Jacobson.  “Predicting efflux ratios and blood-brain barrier penetration from chemical structure: combining passive permeability with active efflux by P-glycoprotein”, ACS Chemical Neuroscience, 4 (2013) 361-367.  Online  PMC3582291

85.

E. Dolghih, C. Bryant, A. R. Renslo, and M. P. Jacobson.  “Predicting binding to P-glycoprotein by flexible receptor docking”, PLoS Computational Biology, 7 (2011) e1002083.  PMC3121697